News Focus
News Focus
Post# of 257262
Next 10
Followers 843
Posts 122802
Boards Moderated 10
Alias Born 09/05/2002

Re: DewDiligence post# 160950

Monday, 06/24/2013 2:44:14 PM

Monday, June 24, 2013 2:44:14 PM

Post# of 257262
NVS starts phase-3 trial of Enbrel FoB:

http://in.reuters.com/article/2013/06/24/us-novartis-enbrel-idINBRE95N05Y20130624

Given the IP protection for Enbrel in the US, which runs until 2028 (#msg-69263618), NVS’ FoB is presumably intended for ex-US markets only.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now